Clinical Trial Update: A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides [Phase 3]

View source ↗

Summary

Phase 3 study evaluating pentamidine plus dapsone for preventing Pneumocystis jirovecii pneumonia in HIV-infected patients unable to take trimethoprim or sulfon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Pneumonia in HIV Infection

Drugs mentioned

• DAPSONE (dapsone)
• Pentamidine (pentamidine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections | Phase 3 | Status: COMPLETED